AAAAI 2022: Improving outcomes for patients with eosinophilic esophagitis

touchCONGRESS for touchRESPIRATORY Listen to Dr Evan Dellon (USA) cover key data presented at AAAAI 2022 Annual Meeting on eosinophilic esophagitis (EoE) including risk factors and pathogenesis, burden of disease and emerging treatment options, as well as expert insights and interpretation from Dr Stuart Carr (Abu Dhabi, UAE) and Dr Alexandra Papadopoulou (Greece). Overview Data review with Dr Evan Dellon (00:55) Expert interview with Dr Evan Dellon, Dr Stuart Carr and Dr Alexandra Papadopoulou (37:05) Interview questions How do the latest data improve our understanding of the pathogenesis of EoE and what are the implications for practice? (37:40) How do the latest data on overlapping atopic conditions in patients with EoE correspond to the patients you manage? (42:23) What are the clinical implications of the data presented from the three-part, phase III trial evaluating dupilumab in patients with EoE? (48:12) Are the presented data on the use of single or multiple biologics in patients with overlapping atopic conditions encouraging? (53:18) What is your key takeaway from AAAAI 2022? (58:27) This touchPODCAST is for HCPs only.   This activity is funded by an unrestricted independent medical educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is provided by touchIME.     For further information visit our website: https://touchrespiratoryime.org/eoe-aaaai-2022/